Type 2 Diabetes Mellitus Clinical Trial
— HAPPYOfficial title:
The HAPPY-study: Digital Support for Healthier Eating Habits in Patients With Diabetes Type 2 - a Randomized Clinical Trial Within Primary Care
Verified date | October 2023 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to investigate the effect of using new app-based technology to improve dietary habits, compared to usual care in patients with type 2 diabetes. The hypothesis is that the intervention, i.e. using the new technology an an app-based course for healthy eating habits, will have a greater positive effect on dietary habits and biological markers, including HbA1c and serum lipids, than usual care.
Status | Completed |
Enrollment | 133 |
Est. completion date | August 31, 2023 |
Est. primary completion date | August 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Have a diagnosis of type 2 diabetes - 18 years of age or older - Ability to communicate in Swedish - Own and use a smartphone with a personal digital ID Exclusion criteria: - No specific exclusion criteria apply |
Country | Name | City | State |
---|---|---|---|
Sweden | Karolinska Institutet | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in dietary intake and eating habits | Assessed using a 94 item food frequency questionnaire (FFQ) | Baseline and month 3, 6 and 12 | |
Other | Change in eating behaviour assessed using Three-Factor Eating Questionnaire-R21 (TFEQ-R21) | Assessed using a 21-item questionnaire | Baseline and month 3, 6 and 12 | |
Other | Change in physical activity assessed using the Active-Q questionnaire | Assessed using a 48 item questionnaire including activities in domains of Daily occupation, transportation, leisure time, and exercise | Baseline and month 3, 6 and 12 | |
Other | Change in self-reported medication use | One question on medication use for blood sugar levels and one questions on medication use for blood lipid levels | Baseline and month 3, 6 and 12 | |
Other | Change in tobacco use habits | Two questions regarding smoking and Swedish snuff use | Baseline and month 3, 6 and 12 | |
Other | Change in sleeping habits | Assessed using a modified 13-item Karolinska Sleep questionnaire | Baseline and month 3, 6 and 12 | |
Other | Change in perceived purpose in Life (PIL) | Assessed using 6-item questionnaire | Baseline and month 3, 6 and 12 | |
Other | Change in perceived stress levels | Assessed using the 14-item perceived stress scale (PSS) | Baseline and month 3, 6 and 12 | |
Other | Change in self-reported diabetes self-efficacy | Assessed using a 20-item questionnaire | Baseline and month 3, 6 and 12 | |
Other | Change in health related quality of life | Assessed using the 36-item RAND-36 questionnaire | Baseline and month 3, 6 and 12 | |
Other | Change in perceived social support from family and friends for healthy eating habits | Assessed using a 3-item questionnaire | Baseline and month 3, 6 and 12 | |
Primary | Change in dietary intake | Change in dietary intake assessed using a four day food record | Baseline and month 3, and 6 | |
Secondary | HbA1c | mmol/mol, Heamoglobin A1c | Baseline and month 3, and 6 | |
Secondary | Total cholesterol | mmol/L | Baseline and month 3, and 6 | |
Secondary | HDL-cholesterol | mmol/L | Baseline and month 3, and 6 | |
Secondary | Triglycerides | mmol/L | Baseline and month 3, and 6 | |
Secondary | Body Mass Index (BMI) | kg/m2, measured height and weight | Baseline and month 3, and 6 | |
Secondary | Body weight | kg, measured | Baseline and month 3, and 6 | |
Secondary | Body composition: Body fat | Body fat (kg), measured using a bioelectrical scale | Baseline and month 3, and 6 | |
Secondary | Body composition: Fat free mass | Fat free mass (kg), measured using a bioelectrical scale | Baseline and month 3, and 6 | |
Secondary | Body composition: Muscle mass | Muscle mass (kg), measured using a bioelectrical scale | Baseline and month 3, and 6 | |
Secondary | Body composition: Total body water | Total body water (kg), measured using a bioelectrical scale | Baseline and month 3, and 6 | |
Secondary | Waist circumference | cm, measured | Baseline and month 3, and 6 | |
Secondary | Blood pressure | mmHg, measured | Baseline and month 3, and 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |